Kallisio has collaborated with Stanford Health Care to support the clinical implementation of its FDA-cleared Stentra system for use in head-and-neck cancer radiation therapy.
A blood test could map the complex ecosystem surrounding cancer cells, offering a more accurate way to predict which patients will benefit from immunotherapy, according to researchers at Mayo Clinic and Stanford Medicine. The test they developed could help guide treatment decisions across multiple cancer types and treatments.
